Animal Health Market is set to reach US$ 119.44 Billion by 2033, North America leads the market with 36% market share.

The Global Animal Health Market size reached US$ 58.64 Billion with a rise of US$ 62.69 Billion in 2024 and is expected to reach US$ 119.44 Billion by 2033, growing at a CAGR of 7.5% during the forecast period 2025-2033.

DataM Intelligence unveils its latest report on the "Animal Health Market size 2025," offering an in-depth analysis of market trends, growth drivers, competitive landscape, and regional dynamics. The study covers market size in value and volume, CAGR forecasts, and emerging opportunities that can guide businesses in seizing growth potential and crafting winning strategies. Packed with data-driven insights on current developments and future trends, this report is essential for companies aiming to stay ahead in the competitive Market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):-https://www.datamintelligence.com/download-sample/animal-health-market?prtk

United States: Key Industry Developments (2025)
✅ December 2025: Zoetis introduced the Vetscan OptiCell, an AI-powered point-of-care hematology analyzer for veterinary clinics that delivers rapid lab-quality blood counts, enhancing diagnostic workflows in U.S. animal care settings.

✅ November 2025: Elanco Animal Health reported increasing clinical adoption of Zenrelia, a novel oral JAK inhibitor for canine dermatology, offering pet owners an effective daily treatment for itching and inflammation.

✅ September 2025: Merck Animal Health showcased Numelvi in new clinical data at a U.S. veterinary conference, highlighting its rapid action and safety for treating allergic dermatitis in dogs, strengthening therapeutic options.

✅ August 2025: Boehringer Ingelheim received FDA approval for a new long-acting injectable treatment for feline diabetes, reducing the need for daily insulin injections and improving chronic disease management in cats.

✅ July 2025: The U.S. USDA granted approval for Elanco's TruCan Ultra CIV canine influenza vaccine, providing broader protection against major H3N2 and H3N8 strains and enhancing preventative care in dogs.

Japan: Key Industry Developments (2025)
✅ November 2025: Zenoaq (Nippon Zenyaku Kogyo) expanded its subsidiary Hundred to specialize in ethical animal welfare solutions and alternative testing methods, reflecting rising corporate focus on humane animal care.

✅ September 2025: Rohto Pharmaceutical launched the Anitto Skin-Care Series for dogs a new supplement line targeting skin health and dermatological wellness, broadening Japan's companion animal product offerings.

✅ April 2025: Sato Yakuhin introduced a chewable pet-human shared supplement, a novel nutraceutical product designed for both pets and their owners to support joint wellness and nutritional balance.

✅ January 2025: Birthbank Co., Ltd. released DearHug, a veterinarian-supervised palatable supplement for dogs and cats aimed at enhancing daily nutrition and overall health in companion animals.

📌 Animal Health Market 2025-26 M&A Deals:-
✅ Companion animals now live in roughly 6 out of 10 households globally, with particularly high pet ownership penetration in developed markets often 65-70% in North America and notable recent growth in Asia-Pacific.

✅ Pet owners increasingly seek premium healthcare, diagnostics, nutrition, and specialized therapeutic products, not just basic veterinary needs a trend often referred to as pet humanization. This significantly broadens demand beyond traditional pharmaceuticals into wellness, diagnostics, and preventive care.

✅ Global demand for animal protein continues to rise amid urbanization and population growth, intensifying livestock production worldwide. This creates sustained demand for vaccines, treatments, feed additives, and biosecurity products.

✅ Outbreaks of zoonotic and chronic conditions such as avian influenza, swine fever, and mastitis have prompted large-scale vaccination and disease control efforts, increasing market uptake of both preventive and therapeutic animal health solutions.

✅ The sector is rapidly integrating technologies such as AI diagnostics, wearable monitoring sensors, telemedicine platforms, and precision livestock tech enabling faster disease detection and remote care, broadening service access, and boosting veterinary productivity.

✅ Adoption of digital tools is especially strong where veterinary infrastructure is less dense, democratizing care access and expanding the addressable market.

Animal Health Market Drivers:-
◾ Advanced testing equipment such as smoking/vaping machines, spectrometers, gas chromatographs, and desktop analytical instruments is increasingly adopted as tobacco producers and third‐party labs invest to meet evolving testing expectations.

◾ Digitalization and integration of data management systems are enabling faster throughput, traceability, and easier compliance reporting a valuable selling point for labs competing on service quality.

◾ Reduced‐harm products and next‐generation nicotine delivery systems (NGPs) require novel assays and multi‐parameter analysis, driving labs to diversify their service portfolios to stay relevant.

◾ Each product category has unique regulatory and health analysis needs, from aerosol testing to flavor compound profiling, encouraging longer‐term contracts and premium pricing for specialized testing services.

◾ Public health campaigns and smoking cessation efforts make verified, tested product data more relevant to stakeholders such as retailers, employers, and insurers supporting ongoing testing demand.

📌 Buy Now & Unlock 360° Market Intelligence:https://www.datamintelligence.com/buy-now-page?report=animal-health-market?prtk

🚆 Key Players:-

Zoetis, Boehringer Ingelheim International GmbH, Elanco, Merck & Co., Ceva, Virbac, Vetoquinol, Dechra, Phibro Animal Health Corporation, and Bimeda US, among others.

1. Zoetis (16% share)
Zoetis is the world's largest pure-play animal health company, focused on veterinary medicines, vaccines, and diagnostics. It leads the industry with a broad global footprint and strong R&D pipeline.

2. Boehringer Ingelheim International GmbH (14% share)
Boehringer Ingelheim's animal health division is a top competitor offering vaccines and therapeutics, with particularly strong presence in livestock vaccines.

3. Merck & Co. (Merck Animal Health) (12% share)
Merck's animal health unit develops vaccines and pharmaceuticals for companion and farm animals, ranking among the largest global players by revenue.

4. Elanco Animal Health (5% share)
Elanco focuses on products for livestock and pets, known for parasite control and anti-infective products; it has grown strongly through strategic acquisitions.

5. Ceva Santé Animale (5% share)
Ceva is a French animal health specialist with a diversified portfolio of vaccines and pharmaceuticals for both livestock and companion animals.

Animal Health Market Regional Highlights
North America
• Holds the largest share of the global animal health market at about 36% .
• Growth driven by advanced veterinary infrastructure, high pet ownership, and strong investment in diagnostics & therapeutics.
• Continued innovation and high adoption of preventive care & digital tools boost regional expansion.

Europe
• Accounts for around 27% of the global animal health market.
• Market development supported by strict animal welfare regulations and preventive healthcare practices.
• Steady growth from expanding companion animal spending and livestock health programs.

Asia Pacific
• Contributes about 23% to global animal health market share.
• Rapid growth driven by expanding livestock farming, rising pet ownership & government disease control initiatives.
• China and India lead development with strong livestock health demand and preventive care uptake.

Get Customization in the report as per your requirements:https://www.datamintelligence.com/customize/animal-health-market?prtk

Animal Health segmentation :
The Animal Health Market by animal type is segmented into production animals and companion animals. Production animals, including cattle, poultry, swine, and sheep, dominate demand due to the need for disease prevention, productivity enhancement, and food safety compliance. Companion animals such as dogs, cats, and horses are witnessing faster growth, driven by rising pet ownership, higher spending on veterinary care, and increasing awareness of preventive healthcare.

Based on product type, the market includes biologics, pharmaceuticals, feed additives, diagnostics, supplements, and others. Pharmaceuticals and biologics hold a major share due to widespread use in disease treatment, vaccination, and infection control. Diagnostics and supplements are gaining traction as early disease detection, preventive nutrition, and wellness-focused care become increasingly important across both livestock and pet health management.

By distribution channel, the market is segmented into hospitals, e-commerce, retail, and others. Veterinary hospitals remain the primary channel due to professional supervision and advanced treatment availability. E-commerce is expanding rapidly, supported by convenience, wider product access, and digital pet care platforms, while retail channels continue to serve routine and over-the-counter animal health product needs.

FAQ'S
Q1. What factors are driving growth in the Animal Health Market?
Growth is driven by rising livestock production, increasing pet ownership, zoonotic disease prevention, and advancements in veterinary pharmaceuticals and diagnostics.

Q2. Which segments hold the largest share in the Animal Health Market?
Pharmaceuticals and biologics dominate, supported by strong demand across production animals and companion animals globally.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription
Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.